Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gut/brain peptide, glucagon like peptide 1 (GLP-1), suppresses food intake by acting on receptors located in key energy balance regulating CNS areas, the hypothalamus or the hindbrain. Moreover, GLP-1 can reduce reward derived from food and motivation to obtain food by acting on its mesolimbic receptors. Together these data suggest a neuroanatomical segregation between homeostatic and reward effects of GLP-1. Here we aim to challenge this view and hypothesize that GLP-1 can regulate food reward behavior by acting directly on the hindbrain, the nucleus of the solitary tract (NTS), GLP-1 receptors (GLP-1R). Using two models of food reward, sucrose progressive ratio operant conditioning and conditioned place preference for food in rats, we show that intra-NTS microinjections of GLP-1 or Exendin-4, a stable analogue of GLP-1, inhibit food reward behavior. When the rats were given a choice between palatable food and chow, intra-NTS Exendin-4 treatment preferentially reduced intake of palatable food but not chow. However, chow intake and body weight were reduced by the NTS GLP-1R activation if chow was offered alone. The NTS GLP-1 activation did not alter general locomotor activity and did not induce nausea, measured by PICA. We further show that GLP-1 fibers are in close apposition to the NTS noradrenergic neurons, which were previously shown to provide a monosynaptic connection between the NTS and the mesolimbic system. Central GLP-1R activation also increased NTS expression of dopamine-β-hydroxylase, a key enzyme in noradrenaline synthesis, indicating a biological link between these two systems. Moreover, NTS GLP-1R activation altered the expression of dopamine-related genes in the ventral tegmental area. These data reveal a food reward-suppressing role of the NTS GLP-1R and indicate that the neurobiological targets underlying food reward control are not limited to the mesolimbic system, instead they are distributed throughout the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Fig 6 GLP-1R stimulation in the NTS decreased food reward behavior. The effect of intra-NTS injection of Ex4 on the ability of palatable food to condition a place preference was tested. Preference for the chamber paired to palatable food was abolished by Ex4 treatment. The preference [% conditioned place preference (CPP)] was calculated using the following formula: ((test − pre-test)/(total time − pre-test)) × 100. n = 11 (vehicle group) and n = 8 (Ex4 group). ****p < 0.0005. Data represent mean ±SEM.](https://figures.cochat.ai/paper-figures/3e3069708b96423f87519f9996ebb86f/activation-of-the-glp-1-receptors-in-the-nucleus-of-the-solitary-tract-reduces-figure-6.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GLP-1 receptors are densely expressed in the hypothalamus (arcuate nucleus) and the hindbrain (area postrema and nucleus of the solitary tract), where their activation enhances satiety signaling and attenuates the hedonic drive for food [31].”
From Adherence and Persistence with GLP-1-Based Therapies: International Real-World Evidence and the Role of Nutritional and Lifestyle Support—A Narrative Review (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Centrally, they activate GLP-1 receptors in the nucleus of the solitary tract and the area postrema, thereby enhancing satiety and attenuating food-related reward through serotonergic and dopaminergic pathways.”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is consistent with some prior studies demonstrating a role for NTS GLP-1R neurons in physiological satiation/satiety and for some of the anorectic effects of various GLP-1RAs, with some reporting an absence of evidence of proxies for nausea (109‐113).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Gene expression values were calculated based on the Ct method [28], where the vehicle-injected group was designated as the calibrator.”
MethodMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“For example orexin, an orexigenic neuropeptide produced in the lateral hypothalamus previously shown to increase food reward behavior [54,55], may be released in the NTS [56,57] to increase the rewarding value of food and food-motivated behavior [20].”
BackgroundA role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 1×
“For example orexin, an orexigenic neuropeptide produced in the lateral hypothalamus previously shown to increase food reward behavior [54,55], may be released in the NTS [56,57] to increase the rewarding value of food and food-motivated behavior [20].”
BackgroundProgressive Ratio as a Measure of Reward Strength
Hodos, W. (1961) · Science · doi:10.1126/science.134.3483.943 · Cited by 1,147
Saper, C. B., Chou, T. C., & Elmquist, J. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00969-8 · Cited by 1,120
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 1×
“Adult female and male mGLU-124 Venus yellow fluorescent protein transgenic mice (YFP-PPG mice; University of Cambridge, United Kingdom [23]) were housed in plastic cages with water and standard chow available ad libitum.”
MethodSelf-citationLarsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Hernandez, L., & Hoebel, B. G. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90036-7 · Cited by 627 · cited 1×
“The intake of palatable food increases the activity of dopamine neurons in the ventral tegmental area (VTA) and the release of dopamine in the nucleus accumbens [6,7].”
Background
Research works printed but not linked: 1
- Alhadeff AL, Rupprecht LE, Hayes MR (2011) GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake. Endocrinology. PMC3275387 22128031 · DOI · Paper page
Cited by
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647
Semaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
GLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
“Notably, GLP-1’s action on gastric emptying has been indicated to be enacted by reduced contraction in human intestinal muscles, and it occurs as a direct result of activation GLP-1R in the gastrointestinal (GI) tract (140), rather than for its ability to mitigate food motivated behavior through receptor activation in…”
BackgroundGLP-1 and weight loss: unraveling the diverse neural circuitry
Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2015 · Cited by 290
Self-citationThe role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“However, GLP-1 receptor activation with exenatide in the VTA, NAc core and NAc shell (Alhadeff et al., 2012) and in the NTS (Richard et al., 2015) have been reported not to produce a pica response.”
BackgroundInfluentialChuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214
“For example, exendin-4 administered into the nucleus accumbens, ventral tegmental area, and NTS reduced food and drug reward behavior (26, 86, 87, 89–97), without producing conditioned taste avoidance or pica behavior (86, 87).”
Longo, S., Rizza, S., & Federici, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02088-x · Cited by 194
“Indeed, administering GLP-1R agonists into the fourth ventricle in mice decreases food intake and body weight [21, 22], and GLP-1R knockdown in NTS neurons increases food intake [23, 23].”
BackgroundGLP-1: Molecular mechanisms and outcomes of a complex signaling system
Smith, N. K., Hackett, T. A., Galli, A., & Flynn, C. R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.010 · Cited by 188
“GLP-1 is also capable of acting within the NTS at local receptors(Card et al., 2018; Richard et al., 2015).”
BackgroundObesity: Current and potential pharmacotherapeutics and targets
Narayanaswami, V., & Dwoskin, L. P. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.015 · Cited by 186
“These findings suggest that NTS GLP-1 receptor activation decreases food reward and motivation for palatable food by modulating mesolimbic DA activity (Richard et al., 2015).”
InfluentialA genetic map of the mouse dorsal vagal complex and its role in obesity
Ludwig, M. Q., Cheng, W., Gordian, D., Lee, J., Paulsen, S. J., Hansen, S. N., Egerod, K. L., Barkholt, P., Rhodes, C. J., Secher, A., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00363-1 · Cited by 186
Anderberg, R. H., Richard, J. E., Hansson, C., Nissbrandt, H., Bergquist, F., & Skibicka, K. P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.021 · Cited by 170
“In addition to serotonin, the GLP-1 system has also been shown to interact with dopamine (Anderberg et al., 2014; Egecioglu et al., 2013; Richard et al., 2015; Sorensen et al., 2015).”
Self-citationGLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1
Xu, F., Lin, B., Zheng, X., Chen, Z., Cao, H., Xu, H., Liang, H., & Weng, J. (2016) · Diabetologia · doi:10.1007/s00125-016-3896-5 · Cited by 157
Vallöf, D., Maccioni, P., Colombo, G., Mandrapa, M., Jörnulf, J. W., Egecioglu, E., Engel, J. A., & Jerlhag, E. (2016) · Addiction Biology · doi:10.1111/adb.12295 · Cited by 150
“2009) as well as food reward behavior in rats (Richard et al. 2015) and may thus be involved in mediating the”
BackgroundLópez-Ferreras, L., Richard, J. E., Noble, E. E., Eerola, K., Anderberg, R. H., Olandersson, K., Taing, L., Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.187 · Cited by 135
Self-citationEren-Yazicioglu, C. Y., Yigit, A., Dogruoz, R. E., & Yapici-Eser, H. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.614884 · Cited by 127
Kabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
“As endogenous GLP-1 is rapidly degraded once it enters circulation, hypothalamic GLP-1 receptors are likely primarily targeted by nucleus tractus solitarius GLP-1 neurons (Kanoski et al., 2016; Richard et al., 2015).”
BackgroundHindbrain circuits in the control of eating behaviour and energy balance
Cheng, W., Gordian, D., Ludwig, M. Q., Pers, T. H., Seeley, R. J., & Myers, M. G. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00606-9 · Cited by 134
Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight
Gaykema, R. P., Newmyer, B. A., Ottolini, M., Raje, V., Warthen, D. M., Lambeth, P. S., Niccum, M., Yao, T., Huang, Y., Schulman, I. G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci81335 · Cited by 123
Hsu, T. M., Noble, E. E., Liu, C. M., Cortella, A. M., Konanur, V. R., Suarez, A. N., Reiner, D. J., Hahn, J. D., Hayes, M. R., & Kanoski, S. E. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.91 · Cited by 122
Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109
GLP-1 Influences Food and Drug Reward
Hayes, M. R., & Schmidt, H. D. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.02.005 · Cited by 108
Sex and estrogens alter the action of glucagon-like peptide-1 on reward
Richard, J. E., Anderberg, R. H., López-Ferreras, L., Olandersson, K., & Skibicka, K. P. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0059-9 · Cited by 102
“GLP-1 can change reward behavior in males [27–31].”
BackgroundSelf-citationAlhadeff, A. L., Mergler, B. D., Zimmer, D. J., Turner, C. A., Reiner, D. J., Schmidt, H. D., Grill, H. J., & Hayes, M. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.246 · Cited by 102
“Recent pharmacological studies have extended the sites of action for GLP-1R-mediated effects on food reward beyond the mesolimbic system to include the NTS (Alhadeff and Grill, 2014b; Richard et al, 2015).”
BackgroundPPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation
Trapp, S., & Cork, S. C. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00333.2015 · Cited by 100
The critical role of CCK in the regulation of food intake and diet-induced obesity
Cawthon, C. R., & Serre, C. B. D. L. (2021) · Peptides · doi:10.1016/j.peptides.2020.170492 · Cited by 104
Thomsen, M., Dencker, D., Wörtwein, G., Weikop, P., Egecioglu, E., Jerlhag, E., Fink‐Jensen, A., & Molander, A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.07.014 · Cited by 100
Fortin, S. M., & Roitman, M. F. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.03.019 · Cited by 90
“Previous research has demonstrated GLP-1 action in other sites that regulate reward responding including the nucleus of the solitary tract, amygdala, NAc and lateral septum [34,93].”
Vogel, H., Wolf, S., Rabasa, C., Rodriguez-Pacheco, F., Babaei, C. S., Stöber, F., Goldschmidt, J., DiMarchi, R. D., Finan, B., Tschöp, M. H., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.039 · Cited by 86
“…the LH. Similar results were obtained with the intra-NTS microinjections, indiating that consistent with previous studies (Alhadeff and Grill, 2014; Richard et al., 2015) NTS is an important brain nucleus for GLP-1-induced reward supression, but does not play a role in the interaction of GLP-1 and…”
BackgroundMethodResultSelf-citationVallöf, D., Kalafateli, A. L., & Jerlhag, E. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.006 · Cited by 84
Vagal Interoceptive Modulation of Motivated Behavior
Maniscalco, J. W., & Rinaman, L. (2018) · Physiology · doi:10.1152/physiol.00036.2017 · Cited by 81
GLP-1 and Its Analogs: Does Sex Matter?
Börchers, S., & Skibicka, K. P. (2025) · Endocrinology · doi:10.1210/endocr/bqae165 · Cited by 77
Self-citationGlucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
Anandhakrishnan, A., & Korbonits, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i20.572 · Cited by 82
Estradiol is a critical regulator of food-reward behavior
Richard, J. E., López‐Ferreras, L., Anderberg, R. H., Olandersson, K., & Skibicka, K. P. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.014 · Cited by 91
Self-citationVallöf, D., Kalafateli, A. L., & Jerlhag, E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00923-1 · Cited by 72
Farkas, E., Szilvásy-Szabó, A., Ruska, Y., Sinkó, R., Rasch, M. G., Egebjerg, T., Pyke, C., Gereben, B., Knudsen, L. B., & Fekete, C. (2021) · Brain Structure and Function · doi:10.1007/s00429-020-02189-1 · Cited by 73
“As intra-NTS administration of GLP-1R agonist regulates food intake and hedonic values of food (Richard et al. 2015), the GLP-1R is obviously functional in this nucleus despite its primarily intracellular localization.”
BackgroundGLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence
Jerlhag, E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.013 · Cited by 72
Boccia, L., Gamakharia, S., Coester, B., Whiting, L., Lutz, T. A., & Le Foll, C. (2020) · Peptides · doi:10.1016/j.peptides.2020.170366 · Cited by 70
“In this regard, sCT has been shown to attenuate the rewarding properties of alcohol in rodents, and more specifically to decrease alcohol-induced locomotor activity, NAc dopamine release, and conditioned place preference in mice, as well as alcohol intake in rats [125].”
InfluentialEffects of the GLP‐1 Agonist Exendin‐4 on Intravenous Ethanol Self‐Administration in Mice
Sørensen, G., Caine, S. B., & Thomsen, M. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13199 · Cited by 69
“…(Dickson et al., 2012; Egecioglu et al., 2013a; Egecioglu et al., 2013b, 2013c; Graham et al., 2013; Shirazi et al., 2013; Alhadeff and Grill, 2014; Richard et al., 2015; Vallöf et al., 2016), and also blunted increases in extracellular striatal dopamine induced by ethanol, nicotine, or stimulants…”
BackgroundVallöf, D., Vestlund, J., & Jerlhag, E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.020 · Cited by 61
“Although activation of GLP-1R sensitive NTS afferents to reward areas including NAc, VTA and LDTg, might provide a possible downstream circuitry for the ability of Ex4-NTS to attenuate alcohol-mediated behaviors, other downstream brain areas should also be considered as potential mediators (Llewellyn-Smith et al., 201…”
InfluentialGuerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110303 · Cited by 62
Konanur, V. R., Hsu, T. M., Kanoski, S. E., Hayes, M. R., & Roitman, M. F. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112771 · Cited by 58
López-Ferreras, L., Eerola, K., Mishra, D., Shevchouk, O. T., Richard, J. E., Nilsson, F. H., Hayes, M. R., & Skibicka, K. P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.11.005 · Cited by 56
Self-citationHamamah, S., Hajnal, A. S., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu16071071 · Cited by 72
“It has been well-described that the activation of GLP-1 receptors in the NTS contributes to food reward-suppressing behaviors through targeting mesolimbic dopamine [161,256].”
BackgroundParallels and Overlap: The Integration of Homeostatic Signals by Mesolimbic Dopamine Neurons
Hsu, T. M., McCutcheon, J. E., & Roitman, M. F. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00410 · Cited by 57
“Interestingly, NTS GLP-1R activation alters the expression of dopamine-related genes in the VTA (182).”
BackgroundBettadapura, S., Dowling, K., Jablon, K., Al-Humadi, A. W., & le Roux, C. W. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01500-y · Cited by 55
Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1
Jerlhag, E. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146562 · Cited by 53
Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids
Ibrahim, I., Soumyakrishnan, S., Ayariga, J. A., Xu, J., Robertson, B. K., SREEPRIYA, M., & Ajayi, O. S. (2022) · Metabolites · doi:10.3390/metabo12121247 · Cited by 62
Woods, C. A., Guttman, Z. R., Huang, D., Kolaric, R. A., Rabinowitsch, A. I., Jones, K. T., Cabeza de Vaca, S., Sclafani, A., & Carr, K. D. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.03.013 · Cited by 52
“…for various metabolic peptides in food reward, including ghrelin, (Abizaid et al., 2006; Malik et al., 2008) leptin (Davis et al., 2011; Figlewicz et al., 2004; Krügel et al., 2003), cholecystokinin (Hajnal et al., 2007), and glucagon-like peptide 1 (Dickson et al., 2012; Richard et al., 2015).”
BackgroundDorton, H. M., Luo, S., Monterosso, J. R., & Page, K. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00297 · Cited by 47
“GLP-1, in particular, has emerged as a possible mediator of processing food reward and other rewarding stimuli through its action in the mesolimbic circuit (26, 27).”
BackgroundAn overview of energy and metabolic regulation
Wen, S., Wang, C., Gong, M., & Zhou, L. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9371-4 · Cited by 55
“The norepinephrine neurons here were shown to link with the mesolimbic area, such as the VTA and NAC (Richard et al., 2015).”
BackgroundFarokhnia, M., Browning, B. D., Crozier, M. E., Sun, H., Akhlaghi, F., & Leggio, L. (2022) · Addiction Biology · doi:10.1111/adb.13211 · Cited by 46
“GLP-1 is synthesized by neurons of the solitary tract that project to mesolimbic regions, such as the nucleus accumbens (NAc) and ventral tegmental area (VTA), that express GLP-1 receptors (GLP-1Rs).(11,12) These regions have a well-documented role not only in food reward but also in the rewarding properties of alcoho…”
BackgroundKatsurada, K., Nakata, M., Saito, T., Zhang, B., Maejima, Y., Nandi, S. S., Sharma, N. M., Patel, K. P., Kario, K., & Yada, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-49364-x · Cited by 46
Ghrelin and Glucagon-Like Peptide-1: A Gut-Brain Axis Battle for Food Reward
Decarie-Spain, L., & Kanoski, S. E. (2021) · Nutrients · doi:10.3390/nu13030977 · Cited by 45
“In fact, the inhibition of lever pressing induced by central administration of exendin-4 is replicated in rats by specific infusion into the NTS [67,68,86], suggesting that the NTS may be mediating the effects of peripheral GLP-1 analog administration on effort-based foodmotivated behavior.”
BackgroundResultInfluentialMetabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights
Geisler, C. E., & Hayes, M. R. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114236 · Cited by 53
Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review
Koshal, P., Jamwal, S., & Kumar, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.015 · Cited by 44
Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis
Diz-Chaves, Y., Gil-Lozano, M., Toba, L., Fandiño, J., Ogando, H., González-Matías, L. C., & Mallo, F. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0118 · Cited by 44
Babic, I., Gorak, A., Engel, M., Sellers, D., Else, P. L., Osborne, A. L., Pai, N. B., Huang, X., Nealon, J. R., & Weston–Green, K. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118756061 · Cited by 48
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Jones, L. A., & Brierley, D. I. (2025) · Endocrinology · doi:10.1210/endocr/bqae167 · Cited by 43
“This is consistent with some prior studies demonstrating a role for NTS GLP-1R neurons in physiological satiation/satiety and for some of the anorectic effects of various GLP-1RAs, with some reporting an absence of evidence of proxies for nausea (109–113).”
Fortin, S. M., Chartoff, E. H., & Roitman, M. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.220 · Cited by 45
GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans
Hanssen, R., Kretschmer, A. C., Rigoux, L., Albus, K., Edwin Thanarajah, S., Sitnikow, T., Melzer, C., Cornely, O. A., Brüning, J. C., & Tittgemeyer, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101163 · Cited by 40
Quast, D. R., Nauck, M. A., Schenker, N., Menge, B. A., Kapitza, C., & Meier, J. J. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14477 · Cited by 39
GLP-1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract
Card, J. P., Johnson, A. L., Llewellyn‐Smith, I. J., Zheng, H., Anand, R., Brierley, D. I., Trapp, S., & Rinaman, L. (2018) · Journal of Comparative Neurology · doi:10.1002/cne.24482 · Cited by 38
Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
Ludwig, M. Q., Todorov, P. V., Egerod, K. L., Olson, D. P., & Pers, T. H. (2021) · Diabetes · doi:10.2337/dbi21-0003 · Cited by 38
“These neurons expressed Th, Ddc, and Dbh and may play a role in decreased preferences for palatable foods seen after intraparenchymal NTS injection of GLP1RA (36), as DBH-immunoreactive NTS neurons project to the nucleus accumbens (a key brain area in food reward processing) (37).”
BackgroundLeptin Sensitizes NTS Neurons to Vagal Input by Increasing Postsynaptic NMDA Receptor Currents
Neyens, D. M., Zhao, H., Huston, N. J., Wayman, G. A., Ritter, R. C., & Appleyard, S. M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1865-19.2020 · Cited by 39
“…that influence feeding, such as the hypothalamus, basolateral amygdala, mesolimbic system, parabrachial nucleus, and dorsal motor nucleus of the vagus (Travagli et al., 1991; Schwartz et al., 2000; García-Medina and Miranda, 2013; Maniscalco and Rinaman, 2014; Richard et al., 2015; Palmiter, 2018).”
BackgroundEvans, B., Stoltzfus, B., Acharya, N., Nyland, J. E., Arnold, A. C., Freet, C. S., Bunce, S. C., & Grigson, P. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.022 · Cited by 39
Friedrich, T., Schalla, M. A., Scharner, S., Kühne, S. G., Goebel‐Stengel, M., Kobelt, P., Rose, M., & Stengel, A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.034 · Cited by 35
GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling
Kooij, K. L., Koster, D. I., Eeltink, E., Luijendijk, M. C. M., Drost, L., Ducrocq, F., & Adan, R. A. H. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103925 · Cited by 39
“GLP-1R agonists applied in the NTS affected dopamine signaling and diminished reward-seeking behaviors (Alhadeff et al., 2012; Richard et al., 2015; Vall ¨ of et al., 2019).”
Lengsfeld, S., Probst, L., Emara, Y., Werlen, L., Vogt, D., Bathelt, C., Baur, F., Caviezel, B., Vukajlovic, T., Fischer, M., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105284 · Cited by 40
The diverse effects of brain glucagon‐like peptide 1 receptors on ingestive behaviour
Williams, D. L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15535 · Cited by 34
“Richard et al. (2015) showed that PPG neuron fibres have close appositions with noradrenergic A2 neurons in the NTS, many of which project to the ventral tegmental area (VTA), the major source of dopamine in the mesolimbic reward pathway, and that NTS application of exendin-4 potently increases…”
BackgroundResultInfluentialLeon, R. M., Borner, T., Reiner, D. J., Stein, L. M., Lhamo, R., Jonghe, B. C. D., & Hayes, M. R. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0384-x · Cited by 28
Kobrzycka, A. T., Napora, P., Pearson, B. L., Pierzchała, K., Szewczyk, R., & Wieczorek, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1544-y · Cited by 29
Mechanisms for the cardiovascular effects of glucagon-like peptide-1
Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 34
“Additionally, the NTS and parabrachial nucleus in the hindbrain also regulates the hypophagic responses to exendin-4 (Richard et al. 2015, Swick et al. 2015).”
BackgroundGLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice
Décarie-Spain, L., Fisette, A., Zhu, Z., Yang, B., DiMarchi, R. D., Tschöp, M. H., Finan, B., Fulton, S., & Clemmensen, C. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.035 · Cited by 27
“, 2015, 2017), NTS (Alhadeff and Grill, 2014; Alhadeff et al., 2017; Richard et al., 2015) and parabrachial nucleus (Alhadeff et al.”
Glucagon-like peptide-1 receptors and sexual behaviors in male mice
Vestlund, J., & Jerlhag, E. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104687 · Cited by 31
“Activation of GLP1R in the NTS may further contribute to reward-regulation in general as previous studies show that Ex4 into the NTS suppresses reward from palatable food (Alhadeff and Grill, 2014; Richard et al., 2015) and alcohol (Vallof et al.”
BackgroundResultChrobok, Ł., Klich, J. D., Sanetra, A. M., Jeczmien‐Lazur, J. S., Pradel, K., Palus‐Chramiec, K., Kępczyński, M., Piggins, H. D., & Lewandowski, M. H. (2021) · The Journal of Physiology · doi:10.1113/jp281838 · Cited by 26
“For example, the peptides orexin and GLP-1 exert potent actions on neuronal activity in the DVC and function as preprandial and postprandial cues, respectively (Peyron et al. 1998; Yang & Ferguson, 2003; Yang et al. 2003; Richard et al. 2015; Fortin et al. 2020).”
BackgroundCawthon, C. R., Blonde, G. D., Nisi, A. V., Bloomston, H. M., Krubitski, B., le Roux, C. W., & Spector, A. C. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad074 · Cited by 30
The (dys)regulation of energy storage in obesity
Levin, B. E., Geary, N., & Lutz, T. A. (2025) · Physiological Reviews · doi:10.1152/physrev.00002.2024 · Cited by 29
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 27
“These effects appear to depend on adrenergic projections to the mesolimbic circuit (Richard et al ., 2015), providing a structural substrate for the regulatory effects of GLP1 on the motivational aspects of food Biological Reviews 99 (2024) 653 – 674 © 2023 Cambridge Philosophical Society.”
BackgroundEffects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
Klausen, M. K., Knudsen, G. M., Vilsbøll, T., & Fink‐Jensen, A. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70004 · Cited by 35
Bernosky‐Smith, K. A., Stanger, D. B., Trujillo, A. J., Mitchell, L. R., España, R. A., & Bass, C. E. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.12.007 · Cited by 24
“Several studies indicate that EX4 differentially effects homeostatic versus hedonic feeding (Aldaheff et al., 2012; Dossat et al., 2001; Richard et al., 2015).”
BackgroundNovelle, M. G., & Diéguez, C. (2018) · European Eating Disorders Review · doi:10.1002/erv.2641 · Cited by 22
Distributed amylin receptor signaling and its influence on motivated behavior
Kern, K. A., & Mietlicki‐Baase, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112958 · Cited by 20
Estrogen and gut satiety hormones in vagus-hindbrain axis
Huang, K.-P., & Raybould, H. E. (2020) · Peptides · doi:10.1016/j.peptides.2020.170389 · Cited by 24
“Furthermore, injection of a GLP-1 agonist into the fourth ventricle reduces the intake of a high palatable diet and reduced the activation of the mesolimbic system and ventral tegmental areas, suggesting GLP-1 signaling in NTS neurons not only induces satiation but also suppresses food reward [130,134].”
BackgroundMella, R., Schmidt, C. B., Romagnoli, P., Teske, J. A., & Perez‐Leighton, C. (2017) · Obesity · doi:10.1002/oby.21939 · Cited by 19
Basolo, A., Heinitz, S., Stinson, E. J., Begaye, B., Hohenadel, M. G., Piaggi, P., Krakoff, J. A., & Votruba, S. B. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0954-5 · Cited by 17
Colvin, K. J., Killen, H. S., Kanter, M. J., Halperin, M. C., Engel, L., Dickinson, M., Fimmel, A. I., Holland, J. G., & Currie, P. J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113726 · Cited by 17
Sex-divergent effects of hindbrain GLP-1-producing neuron activation in rats
López‐Ferreras, L., Asker, M., Krieger, J.-P., & Skibicka, K. P. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1265080 · Cited by 15
Self-citationTongta, S., Sungkaworn, T., & Pathomthongtaweechai, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210974 · Cited by 21
“Key sites include the NTS, CVOs, several hypothalamic nuclei, and the mesolimbic reward pathway, particularly the VTA and NAc [28,30,194].”
InfluentialObesity and Depression: Common Link and Possible Targets
Jitte, S., Keluth, S., Bisht, P., Wal, P., Singh, S., Murti, K., & Kumar, N. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273291985240430074053 · Cited by 15
Ferrari, F., Scheffel, R. S., Martins, V. M., Santos, R. D., & Stein, R. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00515-4 · Cited by 18
Promising new pharmacological targets for depression: The search for efficacy
Tsugiyama, L. E., de Moraes, R. C. M., Moraes, Y. A. C., & de Oliveira, J. F. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103804 · Cited by 17
Douton, J. E., Norgren, R., & Grigson, P. S. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113279 · Cited by 14
Jones, S., LUO, S. H., Dorton, H. M., Yunker, A. G., ANGELO, B. C., DEFENDIS, A. W., Monterosso, J. R., & Page, K. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.638504 · Cited by 16
Asker, M., Krieger, J., Liles, A., Tinsley, I. C., Borner, T., Marić, I., Doebley, S. A., Furst, C. D., Börchers, S., Longo, F., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14937 · Cited by 15
“Guide cannulas (26-gauge; Plastics One, Roanoke, VA, USA) were implanted above the nucleus of the solitary tract (NTS) using coordinates adapted from Richard et al.35 The NTS cannula was implanted at the following coordinates: ±0.75 mm from the midline/on occipital suture/–4.9 mm, with the injector aimed 6.9 mm ventra…”
BackgroundMethodSelf-citationVolcko, K. L., Brakey, D. J., McNamara, T. E., Meyer, M. J., McKay, N. J., Santollo, J., & Daniels, D. (2022) · Appetite · doi:10.1016/j.appet.2022.105943 · Cited by 12
Barana, L., De Fano, M., Cavallo, M., Manco, M., Prete, D., Fanelli, C. G., Porcellati, F., & Pippi, R. (2025) · Nutrients · doi:10.3390/nu18010131 · Cited by 13
“They also stimulate anorexigenic and suppress orexigenic signaling within the hypothalamus and modulate the mesolimbic system, collectively reducing the hedonic drive to eat [4].”
Treesukosol, Y., & Moran, T. H. (2022) · Chemical Senses · doi:10.1093/chemse/bjac004 · Cited by 14
The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review
Iovino, M., Messana, T., Marucci, S., Triggiani, D., Giagulli, V. A., Guastamacchia, E., Piazzolla, G., Pergola, G. D., Lisco, G., & Triggiani, V. (2023) · HORMONES · doi:10.1007/s42000-023-00505-y · Cited by 15
“These effects are related to the food reward-suppressing role of GLP-1 agonists operating within the NTS [51].”
Background
Metadata
- Authors
- Richard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P.
- Affiliations
- University of Gothenburg (SE)
- University of Cambridge (GB)
- Corresponding author
- Skibicka, Karolina P.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-20
- Volume
- 10
- Issue
- 3
- Pages
- e0119034
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4368564
- OpenAlex
- W2070532232
- Cited by
- 168
- References
- 60
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 11 · 2021: 18 · 2020: 13 · 2019: 13 · 2018: 13 · 2017: 12 · 2016: 14 · 2015: 10
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wellcome Trust (WT088357Z/09/Z, WT084210Z/07/Z)
- Novo Nordisk
- Vetenskapsrådet (2011-03054)
- Göteborgs Universitet
- Novo Nordisk Fonden (NNF13OC0003886)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- GLP-1 receptor, nucleus tractus solitarius, food reward, mesolimbic system, exendin-4, noradrenergic neurons, dopamine beta-hydroxylase, ventral tegmental area, palatable food intake, conditioned place preference, hindbrain, energy homeostasis
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Behavior, Animal, Conditioning, Operant, Eating, Female, Food, Male, Motivation, Norepinephrine, Reward, Gene Expression, Solitary Nucleus, Rats, Adrenergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.